Skip to main content
    I

    Ingevity Corp (NGVT)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NYSE

    $60.01
    -1.71 (-2.77%)

    Market Cap: $2.08B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ingevity Corp (NGVT) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Ingevity reported revenue of $1.17B for the fiscal year ended Dec 31, 2025, down 2.7% from the year before. That year, net income was -$167.10M with a net margin of -14.3%, operating cash flow was $331.20M and free cash flow was $273.50M. The quarter ended Sep 30, 2026 had revenue of $305.10M and net income of $49.30M.

    Revenue and Margins

    The operating margin was -3.8% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $908.30M, a compound annual rate of 2.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.17B-2.7%39.5%-3.8%-14.3%
    Dec 2024$1.20B-1.3%38.7%-3.5%-35.9%
    Dec 2023$1.22B-27.1%36.6%16.5%-0.4%
    Dec 2022$1.67B+19.9%34.2%19.4%12.7%
    Dec 2021$1.39B+14.4%36.9%20.9%8.5%
    Dec 2020$1.22B-5.9%38.3%22.5%14.9%
    Dec 2019$1.29B+14.1%37.3%20.9%14.2%
    Dec 2018$1.13B+16.6%36.8%22.3%16.0%
    Dec 2017$972.40M+7.1%33.8%19.7%14.9%
    Dec 2016$908.30MN/A30.2%11.2%4.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income rose 13.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.17B$1.20B$1.22B$1.67B$1.39B$1.22B$1.29B$1.13B$972.40M$908.30M
    Cost of revenue$706.10M$735.30M$770.50M$1.10B$878.70M$750.60M$810.90M$716.80M$643.40M$633.90M
    Gross profit$461.50M$464.80M$445.00M$570.10M$512.80M$465.50M$482.00M$416.80M$329.00M$274.40M
    Research and development$28.40M$24.50M$25.40M$30.30M$26.30M$22.60M$19.70M$21.50M$19.80M$17.60M
    Operating income-$44.00M-$42.50M$200.80M$323.90M$290.40M$273.20M$270.50M$252.60M$191.10M$101.70M
    Net income-$167.10M-$430.30M-$5.40M$211.60M$118.10M$181.40M$183.70M$181.80M$145.20M$44.40M
    EBITDA$37.40M$57.90M$339.80M$432.70M$320.40M$370.50M$359.80M$301.60M$237.10M$137.80M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$305.10M$314.10M$258.00M$185.40M$333.10M$331.50M$247.90M$135.60M$333.80M$390.60M$340.10M-$104.90M
    Gross profit$132.80M$139.00M$116.40M$76.30M$133.90M$127.80M$111.90M$110.30M$131.60M$123.20M$99.70M$32.60M
    Operating income$86.20M$60.10M$68.50M-$56.30M$81.80M-$113.80M$57.00M$178.10M$84.30M-$287.50M-$17.40M$9.50M
    Net income$49.30M$35.30M$59.80M-$84.60M$43.50M-$146.50M$20.50M$16.60M-$107.20M-$283.70M-$56.00M-$116.80M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.21B exceeded cash and equivalents by $1.13B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.65B$2.02B$2.62B$2.74B$2.47B$2.33B$2.14B$1.32B$929.60M$832.80M
    Current assets$454.20M$493.20M$658.60M$683.30M$724.90M$628.70M$463.20M$422.70M$368.70M$295.20M
    Cash and equivalents$78.10M$68.00M$95.90M$76.70M$275.40M$257.70M$56.50M$77.50M$87.90M$30.50M
    Total liabilities$1.62B$1.83B$1.99B$2.04B$1.80B$1.69B$1.61B$976.50M$651.70M$698.20M
    Short-term debt$47.10M$61.30M$84.40M$900.00K$19.60M$26.00M$22.50M$11.20M$9.40M$7.50M
    Long-term debt$1.16B$1.34B$1.38B$1.47B$1.25B$1.27B$1.23B$741.20M$444.00M$481.30M
    Shareholder equity$29.70M$195.20M$631.40M$698.30M$673.80M$642.10M$530.80M$338.70M$263.90M$127.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.50B$1.54B$1.65B$1.65B$1.83B$1.88B$2.06B$2.02B$2.21B$2.28B$2.57B$2.62B
    Total liabilities$1.44B$1.49B$1.61B$1.62B$1.70B$1.76B$1.82B$1.83B$2.00B$1.99B$2.00B$1.99B
    Cash and equivalents$85.40M$97.40M$95.40M$78.10M$83.40M$76.90M$71.50M$68.00M$135.50M$107.40M$88.50M$95.90M
    Shareholder equity$63.00M$46.90M$38.90M$29.70M$138.10M$120.70M$234.60M$195.20M$214.50M$284.80M$568.20M$631.40M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 82.6% of operating cash flow. Share repurchases came to 20.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$331.20M$128.60M$205.10M$313.40M$293.30M$352.40M$275.70M$252.00M$174.30M$127.90M
    Capital expenditures$57.70M$77.60M$109.80M$142.50M$103.80M$82.10M$114.80M$93.90M$52.60M$56.70M
    Free cash flow$273.50M$51.00M$95.30M$170.90M$189.50M$270.30M$160.90M$158.10M$121.70M$71.20M
    Dividends paidN/AN/AN/A$4.10M$4.70M$3.60M$4.10M$95.30M$12.30M$453.90M
    Share repurchases$56.30M$0$92.10M$145.20M$109.40M$88.00M$6.40M$47.40M$6.60M$0
    Investing cash flow-$57.50M-$79.50M-$77.30M-$551.90M-$138.60M-$110.60M-$658.30M-$414.40M-$58.60M-$126.40M
    Financing cash flow-$252.20M-$70.20M-$99.90M$48.10M-$133.10M-$50.20M$369.20M$153.70M-$57.80M-$3.40M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$99.20M-$13.80M-$2.00M$97.10M$129.70M$79.00M$25.40M$64.50M$46.50M$29.70M-$12.10M$46.20M
    Capital expenditures$13.70M$10.30M$10.30M$23.60M$11.90M$12.20M$10.00M$24.90M$18.00M$18.10M$16.60M$29.20M
    Free cash flow$85.50M-$24.10M-$12.30M$73.50M$117.80M$66.80M$15.40M$39.60M$28.50M$11.60M-$28.70M$17.00M
    Last 12 quarters

    Frequently Asked Questions About NGVT

    What is Ingevity's annual revenue?

    Ingevity reported revenue of $1.17B for the fiscal year ended Dec 31, 2025.

    How fast is Ingevity's revenue growing?

    Revenue was down 2.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -11.2%.

    Is Ingevity profitable?

    No. Ingevity reported net income of -$167.10M for the fiscal year ended Dec 31, 2025, with a net margin of -14.3%.

    How much free cash flow does NGVT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $331.20M minus capital expenditures of $57.70M produced free cash flow of $273.50M.

    How much debt does Ingevity have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.16B, short-term debt of $47.10M and cash and equivalents of $78.10M.